ArticlePharmaceuticals (Basel, Switzerland)2022

Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers.

Isak W Tengesdal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.